Are pacemaker properties required for respiratory rhythm generation in adult turtle brain stems in vitro?
The role of pacemaker properties in vertebrate respiratory rhythm generation is not well understood. To address this question from a comparative perspective, brain stems from adult turtles were isolated in vitro, and respiratory motor bursts were recorded on hypoglossal (XII) nerve rootlets. The goal was to test whether burst frequency could be altered by conditions known to alter respiratory pacemaker neuron activity in mammals (e.g., increased bath KCl or blockade of specific inward currents). While bathed in artificial cerebrospinal fluid (aCSF), respiratory burst frequency was not correlated with changes in bath KCl (0.5-10.0 mM). Riluzole (50 microM; persistent Na(+) channel blocker) increased burst frequency by 31 +/- 5% (P < 0.05) and decreased burst amplitude by 42 +/- 4% (P < 0.05). In contrast, flufenamic acid (FFA, 20-500 microM; Ca(2+)-activated cation channel blocker) reduced and abolished burst frequency in a dose- and time-dependent manner (P < 0.05). During synaptic inhibition blockade with bicuculline (50 microM; GABA(A) channel blocker) and strychnine (50 muM; glycine receptor blocker), rhythmic motor activity persisted, and burst frequency was directly correlated with extracellular KCl (0.5-10.0 mM; P = 0.005). During synaptic inhibition blockade, riluzole (50 microM) did not alter burst frequency, whereas FFA (100 microM) abolished burst frequency (P < 0.05). These data are most consistent with the hypothesis that turtle respiratory rhythm generation requires Ca(2+)-activated cation channels but not pacemaker neurons, which thereby favors the group-pacemaker model. During synaptic inhibition blockade, however, the rhythm generator appears to be transformed into a pacemaker-driven network that requires Ca(2+)-activated cation channels.
Johnson
Stephen M
SM
Department of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin, 2015 Linden Drive, Madison, WI 53706, USA. johnsons@svm.vetmed.wisc.edu
Wiegel
Liana M
LM
Majewski
David J
DJ
D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001640:Bicuculline / Q000494:pharmacology; D001683:Biological Clocks / Q000502:physiology*; D002118:Calcium / Q000378:metabolism; D002555:Cerebrospinal Fluid; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D005439:Flufenamic Acid / Q000494:pharmacology; D018756:GABA Antagonists / Q000494:pharmacology; D018684:Glycine Agents / Q000494:pharmacology; D007002:Hypoglossal Nerve / Q000166:cytology / Q000502:physiology*; D066298:In Vitro Techniques; D009046:Motor Neurons / Q000502:physiology; D011189:Potassium Chloride / Q000494:pharmacology; D012125:Respiratory Center / Q000166:cytology / Q000502:physiology*; D015656:Respiratory Mechanics / Q000502:physiology*; D019782:Riluzole / Q000494:pharmacology; D013331:Strychnine / Q000494:pharmacology; D014426:Turtles / Q000502:physiology*
D000893:Anti-Inflammatory Agents; D018691:Excitatory Amino Acid Antagonists; D018756:GABA Antagonists; D018684:Glycine Agents; D005439:Flufenamic Acid; D011189:Potassium Chloride; D019782:Riluzole; D013331:Strychnine; D002118:Calcium; D001640:Bicuculline